Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC.
Heavey S, Godwin P, Baird AM, Barr MP, Umezawa K, Cuffe S, Finn SP, O'Byrne KJ, Gately K.
Heavey S, et al. Among authors: baird am.
Cancer Biol Ther. 2014 Oct;15(10):1367-77. doi: 10.4161/cbt.29841. Epub 2014 Jul 15.
Cancer Biol Ther. 2014.
PMID: 25025901
Free PMC article.